158 related articles for article (PubMed ID: 16105491)
21. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
Selçuk H; Selçuk MT; Maden O
Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
[TBL] [Abstract][Full Text] [Related]
22. Ximelagatran: a new oral anticoagulant.
Hrebickova L; Nawarskas JJ; Anderson JR
Heart Dis; 2003; 5(6):397-408. PubMed ID: 14633322
[TBL] [Abstract][Full Text] [Related]
23. New approaches to anticoagulation in atrial fibrillation.
Petersen P
Curr Cardiol Rep; 2004 Sep; 6(5):354-64. PubMed ID: 15306092
[TBL] [Abstract][Full Text] [Related]
24. Trials and tribulations of non-inferiority: the ximelagatran experience.
Kaul S; Diamond GA; Weintraub WS
J Am Coll Cardiol; 2005 Dec; 46(11):1986-95. PubMed ID: 16325029
[TBL] [Abstract][Full Text] [Related]
25. Ximelagatran compared with warfarin for the prevention of systemic embolism and stroke. An imputed placebo analysis.
Berry C; Norrie J; McMurray JJ
Cardiovasc Drugs Ther; 2005 Mar; 19(2):149-51. PubMed ID: 16025234
[TBL] [Abstract][Full Text] [Related]
26. Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients?
Lip GY; Lane DA
Am J Med; 2010 Sep; 123(9):785-9. PubMed ID: 20655037
[TBL] [Abstract][Full Text] [Related]
27. [Ximelagatran cannot be an alternative to standard warfarin therapy in chronic atrial fibrillation/ antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
Cavuşoğlu Y
Anadolu Kardiyol Derg; 2007 Jun; 7(2):217-8; author reply 218-9. PubMed ID: 17513231
[No Abstract] [Full Text] [Related]
28. Ximelagatran or warfarin in atrial fibrillation?
Epstein EF
Lancet; 2004 Feb; 363(9410):736; author reply 736. PubMed ID: 15001338
[No Abstract] [Full Text] [Related]
29. Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V).
Halperin JL;
Am Heart J; 2003 Sep; 146(3):431-8. PubMed ID: 12947359
[TBL] [Abstract][Full Text] [Related]
30. [Preventing cerebrovascular accidents during atrial fibrillation].
Ederhy S; Meuleman C; Hammoudi N; Janower S; Boccara F; Cohen A
Presse Med; 2005 Oct; 34(18):1315-24. PubMed ID: 16269996
[TBL] [Abstract][Full Text] [Related]
31. Ximelagatran in prevention of cardiovascular events.
Molckovsky D; Boucher M
Issues Emerg Health Technol; 2004 Nov; (62):1-4. PubMed ID: 15565751
[TBL] [Abstract][Full Text] [Related]
32. Ximelagatran or warfarin in atrial fibrillation?
MacAllister R; Hingorani AD; Casas JP
Lancet; 2004 Feb; 363(9410):735-6; author reply 736. PubMed ID: 15001337
[No Abstract] [Full Text] [Related]
33. Ximelagatran or warfarin in atrial fibrillation?
Eikelboom J; Hankey G
Lancet; 2004 Feb; 363(9410):734; author reply 734, 736. PubMed ID: 15001334
[No Abstract] [Full Text] [Related]
34. Ximelagatran or warfarin in atrial fibrillation?
Stöllberger C; Finsterer J
Lancet; 2004 Feb; 363(9410):734-5; author reply 736. PubMed ID: 15001336
[No Abstract] [Full Text] [Related]
35. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.
Lip GY; Frison L; Halperin JL; Lane DA
J Am Coll Cardiol; 2011 Jan; 57(2):173-80. PubMed ID: 21111555
[TBL] [Abstract][Full Text] [Related]
36. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
Tandoğan I
Anadolu Kardiyol Derg; 2007 Jun; 7(2):216; author reply 218-9. PubMed ID: 17513230
[No Abstract] [Full Text] [Related]
37. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
Kiraç FS
Anadolu Kardiyol Derg; 2007 Jun; 7(2):214-5; author reply 218-9. PubMed ID: 17513229
[No Abstract] [Full Text] [Related]
38. Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis.
Lip GY; Edwards SJ
Thromb Res; 2006; 118(3):321-33. PubMed ID: 16198396
[TBL] [Abstract][Full Text] [Related]
39. Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation: experience from the SPORTIF III and V Trials.
Ford GA; Choy AM; Deedwania P; Karalis DG; Lindholm CJ; Pluta W; Frison L; Olsson SB;
Stroke; 2007 Nov; 38(11):2965-71. PubMed ID: 17885258
[TBL] [Abstract][Full Text] [Related]
40. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]